Cargando…

Management of nanomaterials safety in research environment

Despite numerous discussions, workshops, reviews and reports about responsible development of nanotechnology, information describing health and environmental risk of engineered nanoparticles or nanomaterials is severely lacking and thus insufficient for completing rigorous risk assessment on their u...

Descripción completa

Detalles Bibliográficos
Autores principales: Groso, Amela, Petri-Fink, Alke, Magrez, Arnaud, Riediker, Michael, Meyer, Thierry
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3018364/
https://www.ncbi.nlm.nih.gov/pubmed/21143952
http://dx.doi.org/10.1186/1743-8977-7-40
_version_ 1782196047767928832
author Groso, Amela
Petri-Fink, Alke
Magrez, Arnaud
Riediker, Michael
Meyer, Thierry
author_facet Groso, Amela
Petri-Fink, Alke
Magrez, Arnaud
Riediker, Michael
Meyer, Thierry
author_sort Groso, Amela
collection PubMed
description Despite numerous discussions, workshops, reviews and reports about responsible development of nanotechnology, information describing health and environmental risk of engineered nanoparticles or nanomaterials is severely lacking and thus insufficient for completing rigorous risk assessment on their use. However, since preliminary scientific evaluations indicate that there are reasonable suspicions that activities involving nanomaterials might have damaging effects on human health; the precautionary principle must be applied. Public and private institutions as well as industries have the duty to adopt preventive and protective measures proportionate to the risk intensity and the desired level of protection. In this work, we present a practical, 'user-friendly' procedure for a university-wide safety and health management of nanomaterials, developed as a multi-stakeholder effort (government, accident insurance, researchers and experts for occupational safety and health). The process starts using a schematic decision tree that allows classifying the nano laboratory into three hazard classes similar to a control banding approach (from Nano 3 - highest hazard to Nano1 - lowest hazard). Classifying laboratories into risk classes would require considering actual or potential exposure to the nanomaterial as well as statistical data on health effects of exposure. Due to the fact that these data (as well as exposure limits for each individual material) are not available, risk classes could not be determined. For each hazard level we then provide a list of required risk mitigation measures (technical, organizational and personal). The target 'users' of this safety and health methodology are researchers and safety officers. They can rapidly access the precautionary hazard class of their activities and the corresponding adequate safety and health measures. We succeed in convincing scientist dealing with nano-activities that adequate safety measures and management are promoting innovation and discoveries by ensuring them a safe environment even in the case of very novel products. The proposed measures are not considered as constraints but as a support to their research. This methodology is being implemented at the Ecole Polytechnique de Lausanne in over 100 research labs dealing with nanomaterials. It is our opinion that it would be useful to other research and academia institutions as well.
format Text
id pubmed-3018364
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-30183642011-01-11 Management of nanomaterials safety in research environment Groso, Amela Petri-Fink, Alke Magrez, Arnaud Riediker, Michael Meyer, Thierry Part Fibre Toxicol Review Despite numerous discussions, workshops, reviews and reports about responsible development of nanotechnology, information describing health and environmental risk of engineered nanoparticles or nanomaterials is severely lacking and thus insufficient for completing rigorous risk assessment on their use. However, since preliminary scientific evaluations indicate that there are reasonable suspicions that activities involving nanomaterials might have damaging effects on human health; the precautionary principle must be applied. Public and private institutions as well as industries have the duty to adopt preventive and protective measures proportionate to the risk intensity and the desired level of protection. In this work, we present a practical, 'user-friendly' procedure for a university-wide safety and health management of nanomaterials, developed as a multi-stakeholder effort (government, accident insurance, researchers and experts for occupational safety and health). The process starts using a schematic decision tree that allows classifying the nano laboratory into three hazard classes similar to a control banding approach (from Nano 3 - highest hazard to Nano1 - lowest hazard). Classifying laboratories into risk classes would require considering actual or potential exposure to the nanomaterial as well as statistical data on health effects of exposure. Due to the fact that these data (as well as exposure limits for each individual material) are not available, risk classes could not be determined. For each hazard level we then provide a list of required risk mitigation measures (technical, organizational and personal). The target 'users' of this safety and health methodology are researchers and safety officers. They can rapidly access the precautionary hazard class of their activities and the corresponding adequate safety and health measures. We succeed in convincing scientist dealing with nano-activities that adequate safety measures and management are promoting innovation and discoveries by ensuring them a safe environment even in the case of very novel products. The proposed measures are not considered as constraints but as a support to their research. This methodology is being implemented at the Ecole Polytechnique de Lausanne in over 100 research labs dealing with nanomaterials. It is our opinion that it would be useful to other research and academia institutions as well. BioMed Central 2010-12-10 /pmc/articles/PMC3018364/ /pubmed/21143952 http://dx.doi.org/10.1186/1743-8977-7-40 Text en Copyright ©2010 Groso et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<url>http://creativecommons.org/licenses/by/2.0</url>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review
Groso, Amela
Petri-Fink, Alke
Magrez, Arnaud
Riediker, Michael
Meyer, Thierry
Management of nanomaterials safety in research environment
title Management of nanomaterials safety in research environment
title_full Management of nanomaterials safety in research environment
title_fullStr Management of nanomaterials safety in research environment
title_full_unstemmed Management of nanomaterials safety in research environment
title_short Management of nanomaterials safety in research environment
title_sort management of nanomaterials safety in research environment
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3018364/
https://www.ncbi.nlm.nih.gov/pubmed/21143952
http://dx.doi.org/10.1186/1743-8977-7-40
work_keys_str_mv AT grosoamela managementofnanomaterialssafetyinresearchenvironment
AT petrifinkalke managementofnanomaterialssafetyinresearchenvironment
AT magrezarnaud managementofnanomaterialssafetyinresearchenvironment
AT riedikermichael managementofnanomaterialssafetyinresearchenvironment
AT meyerthierry managementofnanomaterialssafetyinresearchenvironment